10-K/A: Creative Medical Technology Holdings Files Amendment to 10-K to Correct Share Count and Audit Report Date
10-K/A Amendment
Creative Medical Technology Holdings files an amendment to its annual report to correct the number of outstanding shares and the date of the independent auditor's report.
Summary
- Creative Medical Technology Holdings filed an amendment (Form 10-K/A) to its annual report for the year ended December 31, 2024.
- The amendment corrects the number of outstanding shares of common stock as of March 14, 2025, and the date of the Report of Independent Registered Accounting.
- The original filing was submitted on March 14, 2025.
- The number of outstanding shares of the registrant's common stock as of March 14, 2025, was 2,535,897.
- The amendment does not modify or update any other information contained in the original filing and does not reflect events occurring after the original filing date.
- The company's common stock is registered on The NASDAQ Stock Market LLC under the trading symbol CELZ.
- As of June 30, 2024, the aggregate market value of the registrant's common stock held by non-affiliates was $5,151,785.
- The financial statements for the years ended December 31, 2024 and 2023, have been audited by Haynie & Company.
- The audit report expresses an opinion that the financial statements present fairly the company's financial position, results of operations, and cash flows in conformity with accounting principles generally accepted in the United States of America.
Sentiment
Score: 7
Explanation: The document is a routine amendment to correct errors, indicating a neutral to slightly positive sentiment as the company is addressing inaccuracies.
Positives
- The company is taking steps to ensure accurate financial reporting by correcting errors in its initial filing.
Industry Context
This is a standard regulatory filing update to correct minor errors in the original filing.
Stakeholder Impact
- Correcting the share count and audit report date ensures accurate information for shareholders.
Key Dates
| Date | Description |
|---|---|
| 2016 | Haynie & Company has served as the Company's auditor since this date. |
| June 30, 2024 | Aggregate market value of non-affiliate common stock was $5,151,785. |
| December 31, 2024 | Fiscal year end date. |
| March 14, 2025 | Original 10-K filing date and date of outstanding shares correction. |
| March 19, 2025 | Date of signatures for the 10-K/A amendment. |
Keywords
10-K/A, amendment, annual report, financial statements, Creative Medical Technology Holdings, CELZ, shares outstanding, audit report
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.